Title | Type | SJR | H index | Total Docs. (2005) | Total Docs. (3years) | Total Refs. (2005) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2005) | %Female (2005) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
64 | International Journal of Gynecological Cancer | journal | 0.537 Q3 | 101 | 265 | 458 | 5989 | 813 | 423 | 1.65 | 22.60 | 33.49 | |
63 | Pathology and Oncology Research | journal | 0.538 Q3 | 61 | 42 | 131 | 1156 | 194 | 127 | 1.55 | 27.52 | 36.55 | |
62 | Chemotherapy | journal | 0.555 Q3 | 61 | 96 | 167 | 2812 | 309 | 160 | 1.69 | 29.29 | 34.95 | |
61 | Leukemia and Lymphoma | journal | 0.559 Q3 | 102 | 272 | 1153 | 8936 | 1739 | 1088 | 1.50 | 32.85 | 33.28 | |
60 | Breast Journal | journal | 0.560 Q3 | 81 | 176 | 388 | 2027 | 564 | 321 | 1.31 | 11.52 | 38.66 | |
59 | Cancer Chemotherapy and Pharmacology, Supplement | journal | 0.562 Q2 | 35 | 0 | 53 | 0 | 87 | 53 | 4.43 | 0.00 | 0.00 | |
58 | Expert Review of Anticancer Therapy | journal | 0.583 Q2 | 85 | 108 | 323 | 7186 | 530 | 288 | 1.81 | 66.54 | 22.73 | |
57 | Cancer Cell International | journal | 0.591 Q2 | 80 | 34 | 40 | 1426 | 57 | 39 | 1.88 | 41.94 | 44.55 | |
56 | Best Practice and Research in Clinical Haematology | journal | 0.622 Q2 | 81 | 55 | 154 | 3315 | 336 | 137 | 2.18 | 60.27 | 31.11 | |
55 | Oncology Reports | journal | 0.652 Q2 | 115 | 440 | 987 | 11396 | 1748 | 987 | 1.74 | 25.90 | 23.60 | |
54 | Prostate Cancer and Prostatic Diseases | journal | 0.656 Q2 | 78 | 64 | 192 | 2153 | 282 | 171 | 1.28 | 33.64 | 22.36 | |
53 | Cancer Practice | journal | 0.667 Q2 | 58 | 0 | 71 | 0 | 122 | 62 | 0.00 | 0.00 | 0.00 | |
52 | Anticancer Research | journal | 0.684 Q2 | 136 | 694 | 2011 | 20756 | 3847 | 2010 | 1.94 | 29.91 | 30.27 | |
51 | Supportive Care in Cancer | journal | 0.691 Q2 | 135 | 139 | 345 | 3851 | 733 | 319 | 1.93 | 27.71 | 42.66 | |
50 | Familial Cancer | journal | 0.703 Q2 | 67 | 54 | 53 | 1659 | 117 | 49 | 2.21 | 30.72 | 44.95 | |
49 | Cancer Treatment and Research | journal | 0.725 Q2 | 65 | 68 | 181 | 7012 | 266 | 181 | 1.52 | 103.12 | 27.39 | |
48 | Cancer Epidemiology | journal | 0.785 Q2 | 86 | 69 | 186 | 2552 | 394 | 186 | 2.05 | 36.99 | 36.65 | |
47 | Acta Oncologica | journal | 0.790 Q2 | 119 | 117 | 297 | 3817 | 709 | 267 | 2.39 | 32.62 | 28.73 | |
46 | Hematological Oncology | journal | 0.821 Q2 | 54 | 20 | 52 | 950 | 115 | 52 | 1.97 | 47.50 | 48.78 | |
45 | Leukemia Research | journal | 0.832 Q2 | 96 | 228 | 556 | 5966 | 1225 | 485 | 2.31 | 26.17 | 39.43 | |
44 | Hereditary Cancer in Clinical Practice | journal | 0.845 Q2 | 31 | 27 | 1 | 587 | 5 | 1 | 5.00 | 21.74 | 51.61 | |
43 | Journal of Neuro-Oncology | journal | 0.850 Q2 | 135 | 249 | 511 | 7832 | 1365 | 485 | 2.74 | 31.45 | 30.56 | |
42 | Cancer Chemotherapy and Pharmacology | journal | 0.877 Q2 | 122 | 175 | 455 | 5518 | 1154 | 455 | 2.43 | 31.53 | 32.04 | |
41 | Surgical Oncology | journal | 0.890 Q2 | 75 | 15 | 88 | 1132 | 245 | 84 | 2.84 | 75.47 | 20.00 | |
40 | European Journal of Surgical Oncology | journal | 0.893 Q2 | 117 | 193 | 480 | 5254 | 1207 | 426 | 2.53 | 27.22 | 21.58 | |
39 | Investigational New Drugs | journal | 0.997 Q2 | 97 | 68 | 149 | 1989 | 435 | 147 | 3.03 | 29.25 | 27.42 | |
38 | Strahlentherapie und Onkologie | journal | 1.013 Q2 | 78 | 104 | 390 | 3649 | 954 | 309 | 2.72 | 35.09 | 23.63 | |
37 | Oncology | journal | 1.022 Q2 | 107 | 153 | 424 | 5248 | 1183 | 412 | 2.48 | 34.30 | 26.01 | |
36 | International Journal of Oncology | journal | 1.054 Q2 | 139 | 398 | 1125 | 9912 | 3127 | 1125 | 2.68 | 24.90 | 29.69 | |
35 | Oral Oncology | journal | 1.060 Q2 | 137 | 138 | 401 | 4187 | 1029 | 375 | 2.51 | 30.34 | 25.94 | |
34 | Journal of Cancer Research and Clinical Oncology | journal | 1.063 Q1 | 109 | 109 | 312 | 3894 | 882 | 310 | 2.90 | 35.72 | 25.75 | |
33 | BMC Cancer | journal | 1.082 Q1 | 160 | 164 | 167 | 5696 | 465 | 167 | 2.40 | 34.73 | 33.99 | |
32 | Lung Cancer | journal | 1.166 Q1 | 148 | 265 | 752 | 6519 | 2229 | 695 | 3.16 | 24.60 | 27.50 | |
31 | Cancer Journal | journal | 1.230 Q1 | 16 | 10 | 0 | 400 | 0 | 0 | 0.00 | 40.00 | 5.88 | |
30 | Pigment Cell and Melanoma Research | journal | 1.270 Q1 | 120 | 60 | 222 | 2669 | 636 | 213 | 2.69 | 44.48 | 40.89 | |
29 | Cancer Immunology, Immunotherapy | journal | 1.313 Q1 | 136 | 125 | 346 | 5847 | 1349 | 339 | 3.84 | 46.78 | 37.79 | |
28 | Psycho-Oncology | journal | 1.326 Q1 | 158 | 103 | 204 | 4490 | 708 | 194 | 2.79 | 43.59 | 65.35 | |
27 | Critical Reviews in Oncology/Hematology | journal | 1.348 Q1 | 144 | 89 | 301 | 9096 | 1243 | 291 | 3.72 | 102.20 | 26.80 | |
26 | Cancer Letters | journal | 1.391 Q1 | 216 | 403 | 1121 | 15182 | 4033 | 1116 | 3.55 | 37.67 | 34.63 | |
25 | Neuro-Oncology | journal | 1.429 Q1 | 163 | 36 | 91 | 1739 | 395 | 87 | 4.16 | 48.31 | 35.92 | |
24 | European Journal of Cancer | journal | 1.452 Q1 | 245 | 360 | 1186 | 15716 | 4463 | 1077 | 3.79 | 43.66 | 35.59 | |
23 | Cancer Causes and Control | journal | 1.522 Q1 | 147 | 142 | 348 | 6269 | 1349 | 331 | 3.70 | 44.15 | 52.12 | |
22 | Breast Cancer Research | journal | 1.577 Q1 | 175 | 203 | 321 | 4092 | 1159 | 299 | 3.56 | 20.16 | 44.33 | |
21 | Annals of Oncology | journal | 1.670 Q1 | 294 | 439 | 1103 | 12151 | 4556 | 898 | 4.08 | 27.68 | 30.02 | |
20 | Molecular Cancer | journal | 1.729 Q1 | 196 | 43 | 87 | 1999 | 340 | 81 | 3.76 | 46.49 | 31.74 | |
19 | Radiotherapy and Oncology | journal | 1.742 Q1 | 182 | 218 | 573 | 5588 | 1955 | 530 | 3.18 | 25.63 | 30.20 | |
18 | Clinical and Experimental Metastasis | journal | 1.755 Q1 | 109 | 82 | 234 | 3430 | 862 | 231 | 3.47 | 41.83 | 40.41 | |
17 | British Journal of Cancer | journal | 1.882 Q1 | 272 | 582 | 2069 | 18021 | 9506 | 1958 | 4.53 | 30.96 | 30.59 | |
16 | Cancer Treatment Reviews | journal | 2.033 Q1 | 164 | 83 | 162 | 3765 | 824 | 132 | 5.54 | 45.36 | 27.56 | |
15 | Endocrine-Related Cancer | journal | 2.065 Q1 | 146 | 95 | 149 | 6239 | 833 | 145 | 5.56 | 65.67 | 39.82 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®